Suchergebnisse - "Verbinnen, Thierry"

PubPharm (37)

1

JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analog suppressed patients with chronic hepatitis B : REEF-2

enthalten in: Journal of hepatology | 2024

von Agarwal, K. | Buti, M. | van Bömmel, F. | +14

2

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1) : a multicentre, double-blind, active-controlled, randomised, phase 2b trial

enthalten in: The lancet. Gastroenterology & hepatology | 2023

von Yuen, M. | Asselah, T. | Jacobson, I. | +116

CommentIn: Lancet Gastroenterol Hepatol. 2023 Sep;8(9):772-773. - PMID 37442151

3

Viral sequence analysis of chronic hepatitis B patients treated with the capsid assembly modulator JNJ-56136379 in the JADE phase 2a study

enthalten in: Antiviral research | 2023

von Verbinnen, T. | Talloen, W. | Janssen, H. | +6

4

Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection

enthalten in: Gut | 2023

von Janssen, H. | Hou, J. | Asselah, T. | +16

5

Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Gane, E. | Schwabe, C. | Berliba, E. | +12

6

Virology analysis of chronic hepatitis B virus-infected patients treated for 28 days with JNJ-56136379 monotherapy

enthalten in: Journal of viral hepatitis | 2020

von Verbinnen, T. | Hodari, M. | Talloen, W. | +7

7

Anti-HBV activity of the HBV capsid assembly modulator JNJ-56136379 across full-length genotype A-H clinical isolates and core site-directed mutants in vitro

enthalten in: The Journal of antimicrobial chemotherapy | 2020

von Verbinnen, T. | Tan, Y. | Wang, G. | +6

8

JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection

enthalten in: Gastroenterology | 2020

von Zoulim, F. | Lenz, O. | Vandenbossche, J. | +13

9

Virology analysis of chronic hepatitis B virus–infected patients treated for 28 days with JNJ‐56136379 monotherapy

enthalten in: Journal of Viral Hepatitis | 2020

von Verbinnen, T. | Hodari, M. | Talloen, W. | +7

10

Systematic review with meta‐analysis : hepatitis B surface antigen decline and seroclearance in chronic hepatitis B patients on nucleos(t)ide analogues or pegylated interferon therapy

enthalten in: GastroHep | 2020

von Slaets, L. | De Ridder, F. | Lenz, O. | +3